ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Research Article

Limitations of care and comorbidities are associated with increased mortality in patients treated with non-invasive ventilation: A retrospective observational study in a single-center ICU.

[version 1; peer review: 2 approved with reservations]
PUBLISHED 27 Aug 2021
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

Abstract

Background: Non-invasive ventilation (NIV) is a common treatment for acute respiratory failure in intensive care units (ICU). While there is increasing data on outcomes after NIV treatment, there are large variations in staffing and monitoring where NIV is provided, making results hard to generalize. The aim of this study was to characterize patients treated with NIV, describe outcomes, and identify factors associated with outcome in an ICU at a Swedish county hospital.

Methods: A single-centre retrospective observational study during 2018 of patients treated with NIV in a six-bed ICU at a Swedish county hospital. Patient characteristics, including comorbidities, details of ICU stay, simplified acute physiology score (SAPS-3), details of NIV treatment and 30-day mortality were collected, and the Charlson co-morbidity index (CCI) was calculated. Primary outcomes were 30-day mortality and associated factors.

Results: 92 patients with mean age (71,3, SD 12,1) were treated with NIV during the study period. 42 (46%) were women. Median CCI was 3 (25th-75th percentiles 1.4)) and median SAPS-3 score was 66 (25th-75th percentiles 58). The 30-day mortality was 37% and in the univariate analysis, SAPS-3 score >66, Charlson comorbidity index, CCI>=3, pCO2 <5.5 and limitation of care were factors associated with increased 30-day mortality. pH <7.35 and pO2<8 at admission showed no associations with 30-day mortality.

Conclusions: We found that patients treated with NIV in ICU were a diverse population where comorbidities and presence of limitations of care might be considered as better predictors of 30-day mortality, rather than physiological parameters.

Keywords

Critical Care,Noninvasive Ventilation, Mortality, Withholding treatment

Introduction

Non-invasive ventilation (NIV), i.e. respiratory support through a non-invasive interface such as a facemask or nasal prongs, is an evolving therapy with a broad application in intensive care units (ICU)13. NIV reduces the risks related to invasive mechanical ventilation in patients with acute respiratory failure in e.g. chronic obstructive pulmonary disease (COPD) and pneumonia4. Further, NIV improves survival after pulmonary oedema and respiratory failure of different aetiologies58.

A delayed start of NIV increases mortality9. Improper selection of patients and continuing treatment when NIV is not sufficient leads to unnecessary harm to the patients and delayed intubation and invasive mechanical ventilation, which is associated with increased mortality10.

The selection of patients who would benefit from an ICU-admission with NIV-treatment is often difficult, as the patients often present with a complex clinical picture11. For decision support, there are several models that predict ICU outcome, such as the Simplified Acute Physiology Score (SAPS-3)12 and the Acute Physiology and Chronic Health Evaluations (APACHE II)13. Further, the Charlson comorbidity index (CCI)14, a frequently used measure of comorbidity, is also able to predict mortality15,16 Patients treated with NIV frequently have “do not intubate” (DNI) orders17,18. It has been shown that the patients with DNI orders treated with NIV for acute respiratory failure who survive have similar life quality after three months compared to patients without limitations of care19.

The settings in which NIV is utilized differs between hospitals and countries where NIV is being increasingly used outside of the ICU4,20. The outcome for patients treated with NIV in the acute care setting for specific diagnoses has been extensively studied7. However, there is limited knowledge of the outcomes in a mixed population receiving non-invasive ventilation at an ICU.

The aim of this study was to describe mortality after NIV at a Swedish county hospital and to identify factors associated with mortality.

Methods

Patient population and study design

A retrospective observational single-centre study conducted in a six-bed ICU at a county hospital (250-bed, Sundsvall, Sweden). Patients >18 years who received NIV in the ICU from January 2018 to December 2018 were included in the study. The study was approved by the Swedish Ethical Review Authority, Uppsala, Sweden (2019-04564, 2019-09-27) and patient consent was waived. The study protocol was performed in accordance with relevant guidelines and the study was registered in clinicaltrials.gov (NCT04115969).

Data collection

Out of the 547 ICU-admissions during 2018, eligible patients were identified in the local ICU-registry. If a patient had more than one ICU-admission during 2018, only the first admission was included. Data sources were medical records, laboratory records, the local ICU-registry and ICU-charts. Variables collected were patient characteristics, admission status (diagnosis, laboratory findings and risk-scoring), details of ventilatory support, arterial blood-gases, limitation-of-care decisions, and 30-day mortality. Further, overall 30-day mortality and the number of patients with limitations of care was retrieved for all patients admitted to the ICU during 2018.

ICU-scoring

The SAPS-3 and APACHE-II-scores were retrieved from the local ICU-registry. The scores were validated for each patient by a review of the records.

Comorbidities

Charlson comorbidity index (CCI) was used to quantify comorbidities and the CCI was calculated with weighting (according to the original study), with a maximum score of 3314.

Statistical analysis

All variables were registered in an anonymized spreadsheet (Excel, version 1902; Microsoft Excel, RRID:SCR_016137. A free alternative software is Google sheets). Data are presented as numbers (rates), mean (standard deviation, SD) or medians (25th-75th percentiles) as appropriate.

The dichotomisation of continuous variables was based on deviations from the normal values (pH<7.35, pO2=<8 kPa, pCO2>5.5 kPa), clinically relevant cut-off points (CCI>=3, RLS (Reaction level scale) >3) or if no data for the decision was available, the median value (SAPS-3).

Univariate analysis was performed using the Chi-2 test to analyse factors associated with 30-day mortality and presented as unadjusted odds-ratios with a corresponding 95% confidence interval. P-values lower than 0.05 were considered statistically significant.

The statistical analyses were performed using SPSS version 25.0 (IBM SPSS Statistics, RRID:SCR_019096). An open-source alternative software is R, which can perform equivalent functions (R Project for Statistical Computing, RRID:SCR_001905).

Results

Patient characteristics

The inclusion of patients is presented in Figure 1. 92 patients were treated with NIV during the study period. The mean age was 71 years (SD 12) and 42 (46%) patients were females. Reason for admission to the ICU included respiratory (n=82; 87%) and/or cardiac causes (n=36; 38%). 30 patients (32%) were admitted from the emergency department, 56 (60%) from a hospital ward, 6 (6%) from the operating theatre and 2 (2%) from other ICUs. Further patient characteristics are presented in Table 1.

5e1c7de4-a6b5-43ef-b1fb-9f5e5c6bfea2_figure1.gif

Figure 1. Screening and inclusion of patients.

Table 1. Patient characteristics at admission to ICU in patients undergoing non-invasive ventilation (n=92) with relation to 30-day mortality.

Day 30 after admission to ICU
VariableAll patients (n=92)Non-survivors (n=34)Survivors (n=58)p-value
Age, years75 (67–80)77 (70–81)72 (65–79)0.15
Female gender, number of patients42 (46%)9 (26%)33 (57%)<0.005
BMI, kg/m230 (26–35)30 (26–33)30 (25–35)1.00
          Missing values BMI, number of patients1037
Charlson comorbidity index (CCI)
        ·      011 (12%)4 (12%)7 (12%)0.073
        ·      1–232 (35%)7 (21%)25 (43%)
        ·      ≥349 (53%)23 (68%)26 (45%)
SAPS–3 score66 (57–77)75 (66–82)62 (55–71)<0.001
Reason for ICU admission, number of patients N.A.
        ·      Observation only1 (1%)0 (0%)1 (2%)
        ·      Cardiac35 (38%)19 (56%)16 (28%)
        ·      Liver1 (1%)0 (0%)1 (2%)
        ·      Gastrointestinal13 (14%)8 (24%)5 (9%)
        ·      Neuro32 (35%)15 (44%)17 (29%)
        ·      Renal24 (26%)14 (41%)10 (17%)
        ·      Respiratory 80 (87%)32 (94%)48 (83%)
        ·      Hematological4 (4%)4 (12%)0 (0%)
        ·      Metabolic36 (39%)17 (50%)19 (33%)
        ·      Trauma2 (2%)0 (0%)2 (3%)
        ·      Other4 (4%)1 (3%)3(5%)
Admitted from, number of patientsN.A.
        ·      Emergency department29 (32%)4 (12%)25 (43%)
        ·      Hospital ward55 (60%)28 (82%)27 (47%)
        ·      Other ICU2 (2%)0 (0%)2 (3%)
        ·      Operating theatre6 (6%)2 (6%)4 (7%)
Reaction Level Scale (RLS)2 (1.3)2 (1.4)2 (1.3)0.67
          Missing values RLS, number of patients202
pH7.29 (7.21–7.35)7.28 (7.21–7.33)7.29 (7.23–7.35)0.33
          Missing values pH, number of patients101
pO2/FiO2 ratio, kPa21.3 (15.4–28.7)18.8 (13.8–25.6)24.8 (16.6–32.3)0.066
          Missing values pO2/FiO2, number of patients303
pCO2,kPa7.3 (4.8–9.5)7.0 (3.9–10)7.4 (5.6–9.3)0.440
          Missing values pCO2, number of patients1129

Data are presented as numbers (%) or median (25th–75th percentile). The Mann-Whitney-U test and the Chi-2 test was used for continuous and categorical variables, respectively, to evaluate statistical differences between the groups. ICU=Intensive Care Unit, BMI=Body mass index, CCI=Charlson comorbidity index, ∙SAPS 3=Simplified Acute Physiology Score, RLS=Reaction Level Scale, N.A=not applicable

Comorbidity

The main comorbidities were chronic heart failure (n=44; 48%), chronic obstructive pulmonary disease (COPD) (n=42; 46%), diabetes mellitus (n=35; 38%), previous myocardial infarction (n=27; 29%), and cerebrovascular disease (n=15; 16%). 11 patients (12%) had a CCI of 0, 33 patients (35%) a CCI of 1 or 2, and 50 patients (54%) a CCI>=3.

Characteristics of ICU stay

The median time spent in the ICU was 1.8 (0.8–5.0) days and the median duration of NIV-treatment was 17 (6–34) hours. 24 patients (26%) were also treated with invasive ventilation during the ICU stay. A total of 38 patients (41%) had limitations of care. 34 (36%) with 'no intubation' and 37 (39%) 'no CPR'. Further details of the ICU stay are presented in Table 2.

Table 2. Characteristics of ICU stay for patients undergoing non-invasive ventilation.

Day 30 after admission to ICU
VariableAll patient
(n=92)
Non-survivors
(n=34)
Survivors (n=58)p-value
Time in ICU, Days1.8 (0.8–5)3.2 (1.2–5.4)1.2 (0.8–3.8)0.096
Limitation of care orders
 -'Do–not–intubate', number of patients33 (36%)19 (56%)14 (24%)0.0022
 -No CPR, number of patients36 (39%)23 (68%)13 (22%)<0.001
Readmission within 72 hours, number of patients6 (6.5%)4 (12%)2 (3%)0.12
NIV treatment time, hours17 (6–34)21 (3–39)15 (7–30)0.82
IPAP cmH2010 (8–13)10 (8–13)10 (8–13)0.66
                         Missing values, number of patients945
EPAP cmH2O6 (5–6)6 (5–7)6 (5–6)0.41
                         Missing values, number of patients725
Invasive ventilation, number of patients (%)24 (26%)11 (32%)13 (22%)0.29
Highflow oxygen, number of patients (%)27 (29%)11 (32%)16 (28%)0.63
pO2/FiO2 ratio at 1–2 hours after start of NIV26 (18.9–30.7)24.2 (14.8–29.8)27 (19.8–30.9)0.16
                         Missing values, number of patients12210
pCO2 at 1–2 hours after start of NIV7.08 (4.9–8.8)6.6 (4.6–8.9)7.38 (5.6–8.7)0.27
                         Missing values, number of patients13310
pH at 1–2 hours after start of NIV7.32 (7.27–7.39)7.30 (7.25–7.37)7.33 (7.28–7.40)0.094
                         Missing values, number of patients12210

Data presented as number (%) or median (25th–75th percentiles). The Mann-Whitney-U test and the Chi-2 test was used for continuous and categorical variables, respectively, to evaluate statistical differences between the groups. ICU-Intensive Care unit; CPR-Cardiopulmonary resuscitation; NIV-Non-invasive ventilation; IPAP-Inspiratory positive airway pressure; EPAP Expiratory positive airway pressure

Outcome and predictors of 30-day mortality

The 30-day mortality in the study cohort was 37% (n=34). In the univariate analysis, SAPS-3 score >66, CCI >=3, pCO2 <5.5 kPa and limitations of care were factors associated with an increased 30-day mortality, see Table 3.

Table 3. Univariate analysis of factors associated with 30-day mortality in a cohort of patients (n=92) treated with non-invasive ventilation at an intensive care unit.

VariableNumber of patients30-day mortalityOdds ratio (95% C.I.)P-value
SAPS–3 score, ≥66 vs. 0–6549/4353% / 19%4.95 (1.9–12.6)<0.001
CCI score, ≥3 vs. 0–249/4347% / 26%2.57 (1.07–6.20)0.034
pH at admission, <7.35 vs. ≥7.3567/2439% / 33%1.27 (0.48–3.33)0.63
pCO2 at admission (kPa), ≥5.5 vs. <5.556/2532% / 56%0.37 (0.14–0.97)0.04
pO2 at admission (kPa), ≥8 vs. <868/2140% / 33%1.32 (0.48–3.61)0.60
BMI (kg·m-2), ≥35 vs. <3518/6428% / 41%0.56 (0.19–1.73)0.32
Age (years), ≥75 vs. <7545/4744% / 30%1.89 (0.80–4.43)0.15
RLS score, ≥3 vs. <330/6237% / 37%0.98 (0.40–2.41)0.97
Limitation of care, yes vs. no38/5463% / 19%7.54 (2.93–19.4)<0.0001

SAPS 3, Simplified acute physiology score; CI, Confidence interval; CCI, Charlson comorbidity index; BMI, body mass index; RLS, Reaction level scale. For the univariate analysis, the Chi-2 test was used.

Characteristics of the ICU

30-day mortality for all patients admitted to the ICU during the study period was 21% (n=547). Further, 12% of all patients had limitations of care.

Discussion

Our retrospective study included all patients treated with NIV at a county hospital ICU during one year. We found that one third of these patients had died within 30 days, and the mortality was almost double compared to all patients admitted to the ICU. Further, 30-day mortality was associated with the presence of co-morbidities and limitations of care.

A recent meta-analysis evaluating noninvasive ventilation and survival in acute care settings showed a hospital mortality of 11%7, a much lower mortality than in our cohort. However, there were great variabilities in the studies included in the meta-analysis, regarding the severity and type of conditions treated. A French study evaluating outcome after acute respiratory failure in 14 different ICUs showed a hospital mortality of 30% in patients treated with NIV, which is comparable to our results4. The high mortality in our cohort might also be explained by advanced age, severity of disease, and a high number of patients with limitations of care.

NIV was used in every fifth patient in our ICU, a higher amount number compared to a study of more than thirteen thousand ICU patients, where 4% received NIV21. This might reflect different practices of NIV globally, where NIV more often is used at wards and intermediary units outside the ICU compared to our study setting.

We found that a high SAPS3-score, a high Charlson Comorbidity Index (CCI), limitation of care and a low pCO2 on admission were associated with an increased mortality. SAPS-3 is a validated score to predict ICU mortality, but when used for patients undergoing NIV in intermediate care units, the prediction accuracy could be lower, but by combining SAPS-3 with patient-risk factors, the mortality prediction can be improved22. This is in line with our results, as we found an association between mortality and co-morbidities.

Further, several studies identify CCI as a predictor of ICU mortality15,16,23. A study of 347 patients outside an ICU undergoing NIV due to pneumonia concluded that in-hospital mortality was mainly associated with patients' co-morbidities and limitations of care, rather than the degree of acute respiratory failure24. The evidence is conflicting however, as others have not found CCI to be a good predictor for short and medium-term outcomes in patients submitted for NIV due to acute respiratory failure25. However, our data indicates that CCI might be considered as a predictor of mortality in NIV patients in an ICU setting.

pCO2 on admission is not included in SAPS3 or APACHE II scoring systems. pCO2 has been studied as a prognostic indicator for patients admitted with pneumonia, but no significant association has been found with mortality26. We found that patients with a high pCO2 had a lower mortality. This might either be explained by a suggested mortality benefit with NIV treatment in hypercapnic COPD patients6 or that patients with normal or low pCO2 had conditions causing respiratory failure with a higher mortality.

41% of our patients had limitations of care, in contrast to all our ICU patients where only 12% hade limitations of care. The observations are in line with a recent meta-analysis which concluded that 27% of patients with acute respiratory failure had a do-not-intubate order27.

It is a difficult clinical task to identify patients that would benefit from NIV treatment, and several factors might influence the selection of patients admitted to an ICU28. Since limitations of care are common among these patients, it is important to set clear goals with the NIV treatment29. An older age, ARDS or pneumonia, or failure to improve after one hour of treatment is associated with higher risk of NIV failure in hypoxemic patients30. Better prediction tools that can be used clinically, before the ICU admission, are needed31.

Except for details of comorbidities, pCO2 and NIV-parameters, our data included the same variables that is sent to/included in the Swedish intensive care registry and this makes it possible to perform similar studies on a national level. However, variables are usually collected during the ICU-stay and many of the variables are not known to the clinician when the decision to start NIV treatment is made. Therefore, a strength with the CCI is that it can be calculated at the time of admission to the ICU, in contrast to physiology-based scores that are dependent on laboratory and bedside clinical data. CCI as a predictor of outcome in the population treated with NIV in ICU has not previously been studied and our study indicates that it might be a usable tool.

Our study has limitations and strengths. Patients treated with NIV are a heterogenous group and NIV was used in many different clinical conditions making it hard to generalize results and our single study setting further decreases external validity. However, even though our study was retrospective, our review of patient records added more variable than included in national intensive care registries. Further, we included almost all patients admitted to our ICU for one year. This is a strength as it reflects a general cohort of patients in the need of NIV treatment.

Conclusions

We conclude that patients treated with NIV in ICU are a diverse population where comorbidities and presence of limitations of care might be considered as better predictors of 30-day mortality, rather than physiological parameters.

List of abbreviations

APACHE II, Acute Physiology and Chronic Health Evaluations II

ARDS, Acute respiratory distress syndrome

CCI, Charlsons co-morbidity index

CI, Confidence Interval

COPD, Chronic obstructive pulmonary disease

CPR, Cardiopulmonary resuscitation

DNI, 'do-not-intubate'

ICU, Intensive care unit

NIV, Non-invasive ventilation

RLS, Reaction level scale

SAPS 3, Simplified Acute Physiology Score 3

SD, Standard deviation

Declarations

Ethical approval and consent to participate

The study was approved by the Swedish Ethical Review Authority (2019-04564, 2019-09-27) and patient consent was waived.

(Swedish Ethical Review Authority, Box 2110, 750 02 Uppsala, Sweden. registrator@etikprovningsmyndigheten.se)

Consent for publication

Not applicable

Availability of data and materials

Data in the study could not be fully de-identified, and according to the General Data Protection Regulation (GDPR), they cannot be publicly shared. Further, the Ethical Review Authority only permitted us to publicly share data on a group level. However, the dataset generated and analysed during the current study are available from the corresponding author (jakob.wallden@umu.se) upon reasonable request. The dataset will be edited to comply with regulations to preserve privacy before being released for a limited use.

Reporting guidelines

Harvard dataverse: "STROBE checklist for 'Limitations of care and comorbidities are associated with increased mortality in patients treated with non-invasive ventilation: A retrospective observational study in a single-center ICU.' https://doi.org/10.7910/DVN/BMQDZ0

Data are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 27 Aug 2021
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Svensk E, Tydén J and Walldén J. Limitations of care and comorbidities are associated with increased mortality in patients treated with non-invasive ventilation: A retrospective observational study in a single-center ICU. [version 1; peer review: 2 approved with reservations]. F1000Research 2021, 10:865 (https://doi.org/10.12688/f1000research.53841.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 27 Aug 2021
Views
5
Cite
Reviewer Report 18 Oct 2021
Hans-Henrik Bülow, Department of Anesthesiology and Intensive Care, Holbaek University Hospital, Region Zealand, Denmark 
Approved with Reservations
VIEWS 5
This paper describes data of one year (2018) of treatment with non-invasive ventilation (NIV) in a single center ICU. The paper is well written with sufficient data to get an impression of the results and conclusions that the authors draw, ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Bülow HH. Reviewer Report For: Limitations of care and comorbidities are associated with increased mortality in patients treated with non-invasive ventilation: A retrospective observational study in a single-center ICU. [version 1; peer review: 2 approved with reservations]. F1000Research 2021, 10:865 (https://doi.org/10.5256/f1000research.57264.r93878)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Views
8
Cite
Reviewer Report 24 Sep 2021
John Botha, Department of Intensive Care Medicine, Frankston Hospital, Frankston, Vic, Australia 
Approved with Reservations
VIEWS 8
This study has all the limitations of a single centre retrospective study. The conclusions that can be drawn are limited and unlikely to provide assistance to clinicians in critical care.

In this, centre NIV ventilation appears to ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Botha J. Reviewer Report For: Limitations of care and comorbidities are associated with increased mortality in patients treated with non-invasive ventilation: A retrospective observational study in a single-center ICU. [version 1; peer review: 2 approved with reservations]. F1000Research 2021, 10:865 (https://doi.org/10.5256/f1000research.57264.r92977)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 27 Aug 2021
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.